Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 6, 2019
Vaccinex, Inc. to Present Data on Its Anti-SEMA4D Compound at the American Association for Cancer Research Annual Meeting 2019
ROCHESTER, N.Y., March 06, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat ...
March 6, 2019
Galmed Pharmaceuticals to Report Fourth Quarter and Year End 2018 Financial Results and Provide Business Update on Wednesday, March 13
TEL AVIV, Israel, March 6, 2019 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmedˮ or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...
March 6, 2019
INVENTIVA to Present Corporate Overview at the Cowen and Company 39th Annual Health Care Conference
Daix (France), March 6, 2019 - Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas ...
March 6, 2019
Bionano Genomics to Present at the Cowen and Company 39th Annual Health Care Conference
SAN DIEGO, March 06, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ...
March 6, 2019
PolarityTE to Present at the 39th Annual Cowen Healthcare Conference and at the 13th Annual Canaccord Genuity Musculoskeletal Conference
SALT LAKE CITY, March 6, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE) announced today that it will attend and present at the Cowen 39th Annual Healthcare Conference ...
March 6, 2019
Pfenex Licensee Successfully Completes a Phase 3 Study and Enters Registration for Pneumosil®
SAN DIEGO, March 06, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that Serum Institute of India Private Limited (SIIPL), has completed ...
March 6, 2019
OncoCyte Corporation to Present at Cowen and Company 39th Annual Health Care Conference in Boston
ALAMEDA, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of cancer, ...
March 6, 2019
Aptevo Announces Proposed Public Offering of Common Stock and Warrants
SEATTLE, March 06, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, today announced ...
February 26, 2019
Neovasc Announces Pricing of $5 Million Public Offering of Common Shares
VANCOUVER, Feb. 26, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today the pricing of its previously announced underwritten ...
February 26, 2019
RedHill Biopharma Provides Full-Year 2018 Financial Results and Operational Highlights
TEL-AVIV, Israel and RALEIGH, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty ...
February 26, 2019
VBL Presents New Data on the Potential of its Novel VB-600 Platform for Nonalcoholic Steatohepatitis (NASH) and Rheumatoid Arthritis (RA)
TEL AVIV, Israel, Feb. 26, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), (the “Company”) today announced new data implicating the potential of its VB-600 ...
February 26, 2019
Foamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting
REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company ...
February 26, 2019
Immutep to Present at Upcoming Industry Conferences
SYDNEY, Australia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments ...
February 26, 2019
electroCore Announces Positive Coverage Policies of gammaCore Issued by Highmark
BASKING RIDGE, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a commercial-stage bioelectronic medicine company, today announced that Highmark, one of the nation’s ...
February 26, 2019
Cellectar Reports Financial Results for Year Ended December 31, 2018 and Provides a Corporate Update
FLORHAM PARK, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs ...
February 26, 2019
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
SAN DIEGO, Feb. 26, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today provided a corporate update and reported financial results for the fourth quarter and ...
February 26, 2019
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
DUBLIN, Feb. 26, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (TBPH) today reported financial results for the fourth quarter and full year ...
February 26, 2019
Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis
LA JOLLA, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat ...
February 26, 2019
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results
MINNEAPOLIS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative ...
February 21, 2019
BioDelivery Sciences to Report Fourth Quarter and Full Year 2018 Financial Results
RALEIGH, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a rapidly growing commercial stage specialty pharmaceutical company dedicated to patients living ...
Page 9 of 138